5-iodo-2-(oxaloamino)benzoic acid has been researched along with 2-(oxaloamino)benzoic acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, HS; Branner, S; Iversen, LF; Jeppesen, CB; Møller, KB; Møller, NP; Norris, K; Rasmussen, HB | 1 |
| Andersen, HS; Bakir, F; Branner, S; Christensen, MS; Collins, T; Hansen, TK; Iversen, LF; Jeppesen, L; Judge, L; Lau, JF; Moran, EJ; Mortensen, SB; Møller, NP; Newman, MJ; Olsen, OH; Ripka, WC; Shahbaz, M; Su, J; Sørensen, AL; Vo, T | 1 |
| Ji, M; Zhou, M | 1 |
| Schürer, SC; Vidović, D | 1 |
| Cheng, Y; Ji, M; Tung, CH; Zhang, F; Zhou, M | 1 |
5 other study(ies) available for 5-iodo-2-(oxaloamino)benzoic acid and 2-(oxaloamino)benzoic acid
| Article | Year |
|---|---|
2-(oxalylamino)-benzoic acid is a general, competitive inhibitor of protein-tyrosine phosphatases.
Topics: Binding Sites; Catalysis; Crystallization; Enzyme Inhibitors; ortho-Aminobenzoates; Oxalates; Protein Tyrosine Phosphatases; Time Factors; X-Ray Diffraction | 2000 |
Discovery and SAR of a novel selective and orally bioavailable nonpeptide classical competitive inhibitor class of protein-tyrosine phosphatase 1B.
Topics: Administration, Oral; Animals; Biological Availability; Cell Line; Crystallography, X-Ray; Deoxyglucose; Enzyme Inhibitors; Mice; Models, Molecular; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatases; Pyridines; Rats; Structure-Activity Relationship; Thiophenes | 2002 |
Molecular docking and 3D-QSAR on 2-(oxalylamino) benzoic acid and its analogues as protein tyrosine phosphatase 1B inhibitors.
Topics: 4-Aminobenzoic Acid; Binding Sites; Enzyme Inhibitors; Humans; Kinetics; Models, Molecular; Molecular Conformation; para-Aminobenzoates; Protein Conformation; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatases; Quantitative Structure-Activity Relationship | 2005 |
Knowledge-based characterization of similarity relationships in the human protein-tyrosine phosphatase family for rational inhibitor design.
Topics: Catalytic Domain; Cluster Analysis; Drug Design; Enzyme Inhibitors; Humans; Knowledge Bases; Models, Molecular; Protein Tyrosine Phosphatases; Sequence Homology, Amino Acid; Structure-Activity Relationship | 2009 |
Studies on two types of PTP1B inhibitors for the treatment of type 2 diabetes: Hologram QSAR for OBA and BBB analogues.
Topics: Diabetes Mellitus, Type 2; Enzyme Inhibitors; Models, Molecular; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Quantitative Structure-Activity Relationship | 2010 |